Mycophenolate mofetil therapy for severe immune thrombocytopenia

British Journal of Haematology

Volumn 171, Issue 4, 2015, Pages 625-630

  Taylor, Alice ^a   Neave, Lucy ^b   Solanki, Shalini ^c   Westwood, John Paul ^a   Terrinonive, Ilaria ^b   Mcguckin, Siobhan ^a   Kothari, Jaimal ^a   Cooper, Nichola ^b   Stasi, Roberto ^c   Scully, Marie ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Immune thrombocytopenia purpura; Mycophenolate mofetil; Platelets

Indexed keywords

AZATHIOPRINE; DANAZOL; DAPSONE; ELTROMBOPAG; IMMUNOGLOBULIN G; MYCOPHENOLATE MOFETIL; RHESUS D ANTIBODY; RITUXIMAB; ROMIPLOSTIM; STEROID; VINCRISTINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ADULT; AGE; AGED; ARTICLE; BRAIN HEMORRHAGE; CLINICAL ARTICLE; COHORT ANALYSIS; COMORBIDITY; DISEASE SEVERITY; DRUG SAFETY; DRUG USE; FEMALE; FOLLOW UP; HUMAN; IMMUNE THROMBOCYTOPENIA PURPURA; MALE; MUCOSAL BLEEDING; PETECHIA; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; VERY ELDERLY; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; COMPLICATION; DRUG SCREENING; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REMISSION; SALVAGE THERAPY; VIRUS INFECTION; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; COMORBIDITY; DRUG EVALUATION; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SPLENECTOMY; VIRUS DISEASES; YOUNG ADULT;

EID: 84945495673     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13622     Document Type: Article

References (20)

1. Aliabadi, A., Cochrane, A.B. & Zuckermann, A.O. (2012) Current strategies and future trends in immunosuppression after heart transplantation. Current Opinion in Organ Transplant, 17, 540-545.
2. Arnold, D.M., Nazi, I., Santos, A., Chan, H., Heddle, N.M., Warkentin, T.E. & Kelton, J.G. (2010) Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenia purpura. Blood, 115, 29-31.
3. Aslam, R., Hu, Y., Gebremeskel, S., Segel, G.B., Speck, E.R., Guo, L., Kim, M., Ni, H., Freedman, J. & Semple, J.W. (2012) Thymic retention of CD4 + CD25 + FoxP3 + T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia. Blood, 120, 2127-2132.
4. Beckebaum, S., Cicinnati, V.R., Radtke, A. & Kabar, I. (2013) Calcineurin inhibitors in liver transplantation - still champions or threatened by serious competitors? Liver International, 33, 656-665.
5. Chow, L., Aslam, R., Speck, E.R., Kim, M., Cridland, N., Webster, M.L., Chen, P., Sahib, K., Ni, H., Lazarus, A.H., Garvey, M.B., Freedman, J. & Semple, J.W. (2010) A murine model of severe immune thrombocytopenia is induced by antibody- and CD8 + T cell-mediated responses that are differentially sensitive to therapy. Blood, 115, 1247-1253.
6. Cines, D.B. & Bussel, J.B. (2001) How I treat ITP. Blood, 106, 2244-2251.
7. Colovic, M., Suvajdzic, N., Colovic, N., Tomin, D., Vidovic, A. & Palibrik, V. (2011) Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults. Platelets, 22, 153-156.
8. Dall'Era, M. (2011) Mycophenolate mofetil in the treatment of systemic lupus erythematosus. Current Opinion Rheumatology, 23, 454-458.
9. Franklin, T.J. & Morris, W.P. (1994) Pharmacodynamics of the inhibition of GTP synthesis in vivo by mycophenolic acid. Advances in Enzyme Regulation, 34, 107-117.
10. Hogan, J., Schwenk, M.H. & Radhakrishnan, J. (2012) Should mycophenolate mofetil replace cyclophosphamide as first-line therapy for severe lupus nephritis? Kidney International, 82, 1256-1260.
11. Howard, J., Hoffbrand, A.V., Prentice, H.G. & Mehta, A. (2002) Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura. British Journal of Haematology, 117, 712-715.
12. Kotb, R., Pinganaud, C., Trichet, C., Lambotte, O., Dreyfus, M., Delfraissy, J., Tchernia, G. & Goujard, C. (2005) Efficacy of mycophenolate mofetil in adult refractory autoimmune cytopenias: a single centre preliminary study. European Journal of Haematology, 75, 60-64.
13. McMillan, R., Wang, L., Tomer, A., Nichol, J. & Pistillo, J. (2003) Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood, 103, 1364-1369.
14. Provan, D., Moss, A.J., Newland, A.C. & Bussel, J.B. (2006) Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura. American Journal of Haematology, 81, 19-25.
15. Provan, D., Stasi, R., Newland, A.C., Blanchette, V.S., Bolton-Maggs, P., Bussel, J.B., Chong, B.H., Cines, D.B., Gernsheimer, T.B., Godeau, B., Grainger, J., Greer, I., Hunt, B.J., Imbach, P.A., Lyons, G., McMillan, R., Rodeghiero, F., Sanz, M.A., Tarantino, M., Watson, S., Young, J. & Kuter, D.J. (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 115, 168-186.
16. Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D.M., Bussel, J.B., Cines, D.B., Chong, B.H., Cooper, N., Godeau, B., Lechner, K., Mazzucconi, M.G., McMillan, R., Sanz, M.A., Imbach, P., Blanchette, V., Kühne, T., Ruggeri, M. & George, J.N. (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood, 113, 2386-2393.
17. Stasi, R. & Newland, A. (2011) ITP: a historical perspective. British Journal of Haematology, 153, 437-450.
18. Stasi, R., Del Poeta, G., Stipa, E., Evangelista, M.L., Trawinska, M.M., Cooper, N. & Amadori, S. (2007) Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood, 110, 2924-2930.
19. Stasi, R., Cooper, N., Del Poeta, G., Stipa, E., Evangelista, M.L., Abruzzese, E. & Amadori, S. (2008) Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood, 112, 1147-1150.
20. Wang, X., Qin, X., Wang, Y., Huang, Z., Li, X., Zeng, Q., Zeng, H., Lu, Y., Wang, L. & Lin, T. (2013) Controlled-dose versus fixed-dose mycophenolate mofetil for kidney transplant recipients: a systematic review and meta-analysis of randomized controlled trials. Transplantation, 96, 361-367.